Showing results (251-260 of 2,056) with videos related to
Sort By:
Pageof 206
Brachytherapy|November 8, 2025
Development of a phantom and analysis of brachytherapy dosimetry using the sulfamic acid/electron paramagnetic resonance systemGhizlane Boukhris, Mohammed Mikou, Omar Rhazouani, et al.Brachytherapy|October 28, 2025
Clinical outcome of high-dose-rate interstitial brachytherapy in vulvar cancer: A single institutional experienceHenna Kärkkäinen, Ester Jääskeläinen, Jan-Erik Palmgren, et al.Brachytherapy|August 15, 2025
Iterative intraoperative 3T MRI (iMRI)-guided brachytherapy: A prospective study on enhancing implantation precision and dosimetric gains in advanced gynecologic cancersShrikiriti S Rajan, Matthew S Ning, Megan Jacobson, et al.Brachytherapy|August 20, 2025
A biologically effective dose-based framework for integrating LDR brachytherapy and EBRT in glioblastoma treatmentAdam C Turner, Elliot M Abbott, Michael A Garcia, et al.Brachytherapy|July 26, 2025
HDR and PDR brachytherapy for facial nonmelanoma skin cancer: Outcome and toxicity assessment for 155 patientsGuillaume Virbel, Kanta Ka, Alexandre Escande, et al.Brachytherapy|July 20, 2014
High-dose-rate interstitial brachytherapy for T1-T2-stage penile carcinoma: short-term resultsDaya Nand Sharma, Nikhil P Joshi, Ajeet Kumar Gandhi, et al.Brachytherapy|July 25, 2014
Toward four-dimensional image-guided adaptive brachytherapy in locally recurrent endometrial cancerLars Fokdal, Gitte Ørtoft, Estrid S Hansen, et al.Brachytherapy|August 3, 2014
Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning studyGeetha Menon, Fleur Huang, Ron Sloboda, et al.Brachytherapy|August 3, 2014
Reirradiation using high-dose-rate brachytherapy in recurrent carcinoma of uterine cervixUmesh Mahantshetty, Nikhil Kalyani, Reena Engineer, et al.Brachytherapy|December 4, 2013
An age-corrected matched-pair study of erectile function in patients treated with dose-escalated adaptive image-guided intensity-modulated radiation therapy vs. high-dose-rate brachytherapy for prostate cancerOvidiu Marina, Jillian Warner, Hong Ye, et al.Pageof 206